Click on company name for all news.
The designation recognizes that Dr. John Langston has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.
Under the terms of the agreements, PATHNOVA will be responsible for the further development and commercialization of the Todos Tests in Singapore, and Todos Medical will assist PATHNOVA in commercializing its nasopharyngeal cancer tests through its affiliates in the United States and Singapore.
InterStim™ Micro Neurostimulator and InterStim™ SureScan™ MRI Leads make Medtronic the only company to offer patients and physicians a choice in SNM systems to match their preferences, lifestyle and treatment goals.
With more than 25 years of experience across manufacturing and industrial industries, Peter Clifford brings strong operational discipline and financial acumen to the role.
Julie L. Bushman is the former Executive Vice President of International Operations for 3M.
These acquisitions bring Ensign's growing portfolio to 226 healthcare operations, 24 of which also include assisted living operations, across thirteen states. Ensign owns the real estate at 92 healthcare operations.
FDA Grants An EUA Amendment Increasing Applied DNA’s COVID-19 Diagnostic Kit Testing Capacity Through Use of Automated RNA Extraction and Expands Supported Platforms
The EUA amendment extends the RT-PCR platform authorization from the Applied Biosystems (ThermoFisher Scientific) QuantStudio™ Dx to include Applied Biosystems’ QuantStudio™ 5 Real-Time PCR system (“QS5”). The amendment also authorizes the use of the Hamilton STARlet robotic automation in conjunction with the Omega Bio-tek Mag-Bind® viral RNA Express kit to speed the process of extracting viral RNA from specimens and drive greater testing throughput.
The study, conducted with oversight by 10 Japanese professional societies, including the Japanese Circulation Society (JCS), is the first to use the Japanese Registry for Percutaneous Ventricular Assist Devices (J-PVAD) to investigate the efficacy and safety of Impella.
Nemours Children’s Health System Announces New Chief Executive of Delaware Valley Operations – Mark Mumford
Mark Mumford will serve as a member of the Executive Cabinet and report to President and Chief Executive Officer R. Lawrence Moss, MD. He will be based in Wilmington, DE at the Nemours Alfred I. duPont Hospital for Children.
"We are thrilled to have had a record number of MolecuLight-based clinical posters and presentations, from so many wound care professionals and settings, be included at the SAWC's Virtual Session", says Anil Amlani, MolecuLight's CEO.
CytoSorbents reports the HemoDefend-BGA filter is designed to enable "universal plasma", or plasma that can be administered to anyone regardless of blood type, and to improve the safety of whole blood transfusions, by the rapid and efficient removal of anti-A and anti-B antibodies from these two blood products.
LabCorp Working With Public Health Authorities on No-Charge Antibody Test Program to Accelerate COVID-19 Blood Plasma Donation
LabCorp, a leading global life sciences company that is deeply integrated in guiding patient care, today announced plans to create a program to offer...
Governor Andrew Cuomo to receive an honorary degree for COVID-19 leadership; national leaders, VCs, and top health industry execs to participate.
GE Healthcare to Distribute Osprey Medical’s Technology to Address Angiography Based Acute Kidney Injury
Under the four-year agreement, GE Healthcare will commercialize Osprey’s DyeVert portfolio which reduces the amount of contrast that reaches the kidney (40% average reduction) with no compromise in image quality.
ACEP urges the public to be circumspect of bold claims or instant cures made on social media or circulating among friends.
The 7D Surgical Machine-vision Image Guidance System is the only approved image guidance system that utilizes a novel and proprietary camera-based technology, coupled with machine-vision algorithms to eliminate the long-standing frustrations with legacy surgical navigational platforms.
Patient Enrollment in the Initial Phase of U.S. Pivotal Clinical Trial for the Beacon Aqueous Microshunt® Completed
This is the U.S. Food and Drug Administration Investigational Device Exemption clinical trial of the Beacon Aqueous Microshunt. Study participants treated during the initial phase of the interventional, single-arm, open-label, multicenter clinical trial will be followed to evaluate safety, performance, and intraocular pressure reduction.
Innovative thin film electrode technology is expected to reach the market soon, prompting medical specialists, healthcare executives and investors to take note of its potential benefits over current technology. Author Dave Rosa, President and CEO of NeuroOne Medical Technologies provides exceptional information and advice.
The Honorable Andrew Weber served as the Assistant Secretary of Defense for Nuclear, Chemical & Biological Defense Programs under President Obama.
Dan Beuerlein will spearhead Agape Care’s business development initiatives for expansion to surrounding states.
Kubota Vision completed a successful clinical study in October 2018 that demonstrated the PBOS could detect thinning and thickening of the human retina over time when compared to results from an established commercial OCT device.
United States Blood Glucose Meter Market Insights Report - The United States market for the blood glucose meter is primarily expected to be driven...